Safety and tolerability results of a phase 2b extension study of the novel oral fumarate BG00012 for the treatment of relapsing-remitting multiple sclerosis

Author
Meluzinova, Eva
O'Neill, Gilmore
Yang, Minhua
ERAKSOY, Mefküre
Rektor, Ivan
Kappos, Ludwig
Gold, Ralf
Miller, David
MacManus, David G.
Havrdova, Eva
Limmroth, Volker
Polman, Chris
Schmierer, Klaus
Yousry, Tarek
Metadata
Show full item record
URI
http://hdl.handle.net/20.500.12627/177152
Collections